You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Monday, February 26, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - THURSDAY, JULY 14TH, 2022
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 30431.53 -341.26 (-1.11%) | NASDAQ 11160.84 -86.75 (-0.77%) | S&P 500 3765.94 -35.84 (-0.94%)
|
Time of Screening :
7/14/2022 12:24:23 PM Report Released :
7/14/2022 12:38:59 PM
Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High
Volume Is:
At least 45% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
CI
- NYSE
Cigna Corp
|
$264.38
|
-9.38
-3.42%
|
$266.82
|
862,988
45.02% of 50 DAV
50 DAV is 1,917,000
|
$282.33
-6.36%
|
7/7/2022 |
$276.55
|
PP = $273.68
MB = $287.36 |
Most Recent Note - 7/14/2022 12:30:05 PM
Y - Gapped down today undercutting prior highs in the $273 area raising concerns while testing support near its 50 DMA line ($261.90), retreating from its all-time high hit this week. More damaging losses would raise greater concerns.
>>> The latest Featured Stock Update with an annotated graph appeared on 7/7/2022. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
ABBV
- NYSE - Medical-Ethical Drugs
AbbVie Inc
|
$150.05 |
-0.69
-0.46%
|
$150.58
|
$175.91
|
-14.70% |
3,911,542
61.79%
|
6,330,000
|
Most Recent Note for ABBV - 7/14/2022 12:26:58 PM
Retreated from its all-time high testing its 200 DMA line since last noted with caution in the 4/19/22 mid-day report. Reported earnings +9% on +4% sales revenues for the Mar '22 quarter versus the year ago period. Quarterly and annual earnings history is not a match with the fact-based investment system.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZN
- NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
|
$64.75 |
-1.55
-2.34%
|
$65.02
|
$71.70
|
-9.69% |
3,241,586
47.21%
|
6,866,000
|
Most Recent Note for AZN - 7/14/2022 12:27:34 PM
Consolidating near its 50 DMA line after finding support near its 200 DMA line. Little resistance remains due to overhead supply up to the $71 level. Prior mid-day reports noted - "Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ECPG
- NASDAQ - FINANCIAL SERVICES - Credit Services
Encore Capital Group Inc
|
$62.93 |
-2.90
-4.41%
|
$65.40
|
$72.67
|
-13.40% |
268,253
89.12%
|
301,000
|
Most Recent Note for ECPG - 7/14/2022 12:31:23 PM
Pulling back today following volume-driven gains. The prior mid-day report cautioned members - "Reported the Mar '22 quarter with strong +115% earnings on +20% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ELA
- AMEX - Retail/Whlsle-Jewelry
Envela Corporation
|
$7.30 |
-0.25
-3.31%
|
$7.70
|
$7.74
|
-5.69% |
43,144
53.26%
|
81,000
|
Most Recent Note for ELA - 7/14/2022 12:32:39 PM
Perched at its all time high after volume-driven gains. Prior mid-day reports noted - "Reported strong Mar '22 quarterly results versus the year ago period. Prior sales revenues and earnings history has not been a great match with the fact-based investment system's fundamental guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GIS
- NYSE - FOOD & BEVERAGE - Food - Major Diversified
General Mills Inc
|
$74.71 |
-1.72
-2.25%
|
$75.77
|
$76.94
|
-2.90% |
2,138,689
54.98%
|
3,890,000
|
Most Recent Note for GIS - 7/14/2022 12:33:38 PM
Pulling back today from its all-time high after noted volume-driven gains. Prior mid-day reports cautioned members - "Sub par sales revenues increases and earnings versus year ago quarterly comparisons through May '22 versus the year ago period. Annual earnings growth has been slow and steady for this well-known name in the Food - Packaged industry group. Fundamentals fall short of the C and A criteria of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GSK
- NYSE - Medical-Diversified
Glaxosmithkline Plc Adr
|
$40.03 |
-0.89
-2.17%
|
$40.13
|
$46.97
|
-14.78% |
3,096,282
51.23%
|
6,044,000
|
Most Recent Note for GSK - 7/14/2022 12:34:11 PM
Slumping further below its 200 DMA line again with today's 5th consecutive loss. Recently met resistance near its 50 DMA line. Prior mid-day reports noted - "UK-based pharmaceuticals firm's quarterly comparisons through Mar '22 have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GWW
- NYSE - WHOLESALE - Electronics Wholesale
Grainger W W Inc
|
$451.95 |
-2.40
-0.53%
|
$453.09
|
$529.91
|
-14.71% |
141,906
46.22%
|
307,000
|
Most Recent Note for GWW - 7/14/2022 12:35:48 PM
Met resistance at its 200 DMA line ($481) recently and it is testing prior lows in the $440 area with today's 3rd consecutive loss. Noted with caution in the 4/14/22 mid-day report after wedging to new all-time highs with gains lacking great volume conviction. Reported earnings +58% on +18% sales revenues for the quarter ended March 31, 2022 versus the year ago period marking its 3rd consecutive quarterly comparison above the minimum +25% earnings guideline (C criteria). The annual earnings history for this Retail/Wholesale Building Products firm has been up and down which raises concerns with respect to the A criteria of the fact-based investment system's guidelines.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RBA
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
Ritchie Bros Auctioneers
|
$66.04 |
+5.70
9.45%
|
$66.54
|
$76.18
|
-13.31% |
799,463
158.94%
|
503,000
|
Most Recent Note for RBA - 7/14/2022 12:37:25 PM
Rebounding impressively with today's big volume driven gain after a pullback on the prior session tested support near its 50 and 200 DMA lines which closely coincide. Prior mid-day reports cautioned members - "Reported earnings +540% on +19% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
USAK
- NASDAQ - TRANSPORTATION - Trucking
U S A Truck Inc
|
$31.20 |
+0.10
0.32%
|
$31.29
|
$31.67
|
-1.48% |
134,488
49.26%
|
273,000
|
Most Recent Note for USAK - 7/14/2022 12:38:06 PM
Holding its ground in a tight range near its 52-week high after a gap up on 6/24/22 M&A news. Recent quarterly comparisons through Mar '22 were strong but its prior earnings history is not a match with the fundamental guidelines of the fact-based investment system.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VIVO
- NASDAQ - DRUGS - Diagnostic Substances
Meridian Bioscience Inc
|
$32.63 |
-0.33
-0.99%
|
$33.03
|
$34.38
|
-5.10% |
567,782
74.71%
|
760,000
|
Most Recent Note for VIVO - 7/14/2022 12:38:50 PM
Consolidating in a tight range near its 52-week high following volume-driven gains after M&A news. Prior mid-day reports cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
